Recent experience shows the PBAC does not need new powers or a revised policy framework to enable accelerated access to new medicines or vaccines. The minister can give direction to prioritise faster access, and companies need confidence in existing arrangements. …
Building confidence in existing arrangements is the most obvious solution
April 11, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
Access delayed - the stakes are high for the industry's next agreements
October 27, 2026 - - Latest News -
Services Australia annual report confirms decline in prescription volume
October 27, 2026 - - Latest News -
CSL announces new chair as Brian McNamee prepares to bow out
October 26, 2026 - - Latest News -
There is an urgent need to reconsider the question of PBS sustainability
October 26, 2026 - - Latest News -
PBS share of health spending on track to halve as Canberra prepares to negotiate with industry
October 26, 2026 - - Latest News -
Documents reveal net PBS spending set to remain on life support to the end of decade
October 26, 2026 - - Latest News -
Health's multi-million dollar rebuild of cost-recovery fees is happening out of view
October 26, 2026 - - Latest News